• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前哨淋巴结微转移在浸润性乳腺癌中的临床意义]

[Clinical significance of sentinel lymph node micrometastases in invasive breast carcinoma].

作者信息

Tsugawa Koichiro

机构信息

Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

出版信息

Nihon Geka Gakkai Zasshi. 2013 Jan;114(1):22-7.

PMID:23457941
Abstract

Axillary lymph node status is one of the most important prognostic factors in patients with invasive breast carcinoma. Sentinel lymph node biopsy leads to more accurate examination of the lymph nodes and has resulted in an increased detection rate of small cancer deposits. Patients with micrometastatic foci can have nonsentinel lymph node involvement, including macrometastatic foci. Sentinel lymph node micrometastases are associated with an adverse impact on disease recurrence or survival. Axillary clearance offers no advantage in reducing the incidence of disease recurrence and survival. However, the long-term outcomes can be improved with the use of adjuvant systemic therapy, and it would be reasonable to consider systemic treatment in these patients.

摘要

腋窝淋巴结状态是浸润性乳腺癌患者最重要的预后因素之一。前哨淋巴结活检可更准确地检查淋巴结,并提高了微小癌灶的检出率。有微转移灶的患者可能存在非前哨淋巴结受累,包括宏转移灶。前哨淋巴结微转移对疾病复发或生存有不利影响。腋窝清扫在降低疾病复发率和提高生存率方面并无优势。然而,使用辅助性全身治疗可改善长期预后,因此考虑对这些患者进行全身治疗是合理的。

相似文献

1
[Clinical significance of sentinel lymph node micrometastases in invasive breast carcinoma].[前哨淋巴结微转移在浸润性乳腺癌中的临床意义]
Nihon Geka Gakkai Zasshi. 2013 Jan;114(1):22-7.
2
Clinical significance and management of sentinel node micrometastasis in invasive breast cancer.浸润性乳腺癌前哨淋巴结微转移的临床意义及处理。
Clin Breast Cancer. 2012 Oct;12(5):308-12. doi: 10.1016/j.clbc.2012.07.012.
3
Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.腋窝和全身治疗患有乳腺癌和前哨淋巴结中有微转移疾病或孤立肿瘤细胞的患者。
Breast. 2012 Aug;21(4):524-8. doi: 10.1016/j.breast.2012.03.008. Epub 2012 Apr 18.
4
[Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].[对我们993例乳腺癌手术前哨淋巴结活检初始经验的批判性研究]
Bull Cancer. 2008 Jul-Aug;95(7):763-72. doi: 10.1684/bdc.2008.0640.
5
Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.前哨淋巴结引导下腋窝淋巴结清扫术引入后乳腺癌女性患者的分期
Dan Med J. 2012 Jul;59(7):B4475.
6
A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.一种简单的列线图,用于评估前哨淋巴结受累微小的乳腺癌患者发生非前哨淋巴结转移的风险。
Ann Surg Oncol. 2012 Feb;19(2):567-76. doi: 10.1245/s10434-011-1882-1. Epub 2011 Jul 27.
7
Pathologic Evaluation and Prognostic Implications of Nodal Micrometastases in Breast Cancer.乳腺癌淋巴结微转移的病理评估及预后意义。
Semin Radiat Oncol. 2019 Apr;29(2):102-110. doi: 10.1016/j.semradonc.2018.11.001.
8
[Micrometastasis: biological entity and clinical impact?].[微转移:生物学实体及临床影响?]
Bull Cancer. 2013 Apr 1;100(4):351-6. doi: 10.1684/bdc.2013.1726.
9
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.前哨淋巴结作为乳腺癌患者治疗规划的新标志物。
J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022.
10
Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma.乳腺癌腋窝前哨淋巴结隐匿性转移的发生率
Pol J Pathol. 2012 Mar;63(1):40-4.